BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 17509507)

  • 1. Tear evaporation rates in Sjögren syndrome and non-Sjögren dry eye patients.
    Goto E; Matsumoto Y; Kamoi M; Endo K; Ishida R; Dogru M; Kaido M; Kojima T; Tsubota K
    Am J Ophthalmol; 2007 Jul; 144(1):81-85. PubMed ID: 17509507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meibomian gland dysfunction in patients with Sjögren syndrome.
    Shimazaki J; Goto E; Ono M; Shimmura S; Tsubota K
    Ophthalmology; 1998 Aug; 105(8):1485-8. PubMed ID: 9709762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive interference tear meniscometry in dry eye patients with Sjögren syndrome.
    Uchida A; Uchino M; Goto E; Hosaka E; Kasuya Y; Fukagawa K; Dogru M; Ogawa Y; Tsubota K
    Am J Ophthalmol; 2007 Aug; 144(2):232-237. PubMed ID: 17533107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential changes of lipid tear film after the instillation of a single drop of a new emulsion eye drop in dry eye patients.
    Di Pascuale MA; Goto E; Tseng SC
    Ophthalmology; 2004 Apr; 111(4):783-91. PubMed ID: 15051213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical characteristics of patients with dry eye syndrome].
    Zhang M; Chen JQ; Liu ZG; Lou LH; Xiao QG; Yao Y; Chen LS; Zhang ZH
    Zhonghua Yan Ke Za Zhi; 2003 Jan; 39(1):5-9. PubMed ID: 12760805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
    Solomon A; Dursun D; Liu Z; Xie Y; Macri A; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2283-92. PubMed ID: 11527941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tear lipocalin and lysozyme in Sjögren and non-Sjögren dry eye.
    Caffery B; Joyce E; Boone A; Slomovic A; Simpson T; Jones L; Senchyna M
    Optom Vis Sci; 2008 Aug; 85(8):661-7. PubMed ID: 18677232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of tear cytokines and clinical correlations in Sjögren syndrome dry eye patients and non-Sjögren syndrome dry eye patients.
    Lee SY; Han SJ; Nam SM; Yoon SC; Ahn JM; Kim TI; Kim EK; Seo KY
    Am J Ophthalmol; 2013 Aug; 156(2):247-253.e1. PubMed ID: 23752063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic significance of Fourier-domain optical coherence tomography in Sjögren syndrome, aqueous tear deficiency and lipid tear deficiency patients.
    Qiu X; Gong L; Lu Y; Jin H; Robitaille M
    Acta Ophthalmol; 2012 Aug; 90(5):e359-66. PubMed ID: 22568661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome.
    Yoon KC; Jeong IY; Park YG; Yang SY
    Cornea; 2007 May; 26(4):431-7. PubMed ID: 17457192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjunctival in vivo confocal scanning laser microscopy in patients with Sjögren syndrome.
    Wakamatsu TH; Sato EA; Matsumoto Y; Ibrahim OM; Dogru M; Kaido M; Ishida R; Tsubota K
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):144-50. PubMed ID: 19696170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manifestation of meibomian gland dysfunction in patients with Sjögren's syndrome, non-Sjögren's dry eye, and non-dry eye controls.
    Kang YS; Lee HS; Li Y; Choi W; Yoon KC
    Int Ophthalmol; 2018 Jun; 38(3):1161-1167. PubMed ID: 28567496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tear physiology in dry eye associated with chronic GVHD.
    Khanal S; Tomlinson A
    Bone Marrow Transplant; 2012 Jan; 47(1):115-9. PubMed ID: 21383687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of IL-21 cytokine with severity of primary Sjögren syndrome dry eye.
    Lim SA; Nam DH; Lee JH; Kwok SK; Park SH; Chung SH
    Cornea; 2015 Mar; 34(3):248-52. PubMed ID: 25603233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infrared imaging of meibomian glands and evaluation of the lipid layer in Sjögren's syndrome patients and nondry eye controls.
    Menzies KL; Srinivasan S; Prokopich CL; Jones L
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):836-41. PubMed ID: 25574045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Meibomian Gland Imaging Findings and Lipid Layer Thickness between Primary Sjögren Syndrome and Non-Sjögren Syndrome Dry Eyes.
    Hwang JH; Lee JH; Chung SH
    Ocul Immunol Inflamm; 2020; 28(2):182-187. PubMed ID: 30794472
    [No Abstract]   [Full Text] [Related]  

  • 17. Tear film dynamics in floppy eyelid syndrome.
    Liu DT; Di Pascuale MA; Sawai J; Gao YY; Tseng SC
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1188-94. PubMed ID: 15790878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tear function and lipid layer alterations in dry eye patients with chronic graft-vs-host disease.
    Ban Y; Ogawa Y; Goto E; Uchino M; Terauchi N; Seki M; Nakaya M; Saiki M; Mori T; Okamoto S; Matsumoto Y; Dogru M; Shimazaki J; Tsubota K
    Eye (Lond); 2009 Jan; 23(1):202-8. PubMed ID: 19011604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antibacterial honey on the ocular flora in tear deficiency and meibomian gland disease.
    Albietz JM; Lenton LM
    Cornea; 2006 Oct; 25(9):1012-9. PubMed ID: 17133045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated tear interleukin-6 levels in patients with Sjögren syndrome.
    Tishler M; Yaron I; Geyer O; Shirazi I; Naftaliev E; Yaron M
    Ophthalmology; 1998 Dec; 105(12):2327-9. PubMed ID: 9855167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.